Caspofungin for amphotericin B resistant fungal infection following allogeneic stem cell transplantation

被引：0
|
作者：
Schade, U
Kröger, N
Zabelina, T
Renges, H
Krüger, W
Tögel, F
Ayuk, F
Hansen, A
Fiegel, H
Hessling, J
Kordes, U
Erttmann, R
Zander, A
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P856
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [21] Caspofungin is highly effective as secondary prophylaxis in allogeneic stem cell transplantation in patients with prior systemic or invasive fungal infections
    Stute, N
    Kratochwille, A
    Zabelina, T
    Fehse, N
    Hassenpflug, W
    Panse, J
    Woltschke, C
    Ayuketang, F
    Schieder, H
    Renges, H
    von Hinüber, R
    Kabisch, H
    Zander, AR
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2004, 33 : S191 - S191
  • [22] Caspofungin is highly effective as secondary prophylaxis in allogeneic stem cell transplantation in patients with prior systemic or invasive fungal infections
    Stute, N
    Kratochwille, A
    Zabelina, T
    Fehse, N
    Hassenpflug, W
    Panse, J
    Woltschke, C
    Ayuketang, F
    Schieder, H
    Renges, H
    von Hinüber, R
    Kabisch, H
    Zander, AR
    Kroger, N
    BLOOD, 2003, 102 (11) : 977A - 977A
  • [23] Prophylaxis for invasive fungal infection in pediatric patients with allogeneic hematopoietic stem cell transplantation
    Perez, Paola
    Patino, Jaime
    Franco, Alexis A.
    Rosso, Fernando
    Beltran, Estefania
    Manzi, Eliana
    Castro, Andres
    Estacio, Mayra
    Medina Valencia, Diego
    BLOOD RESEARCH, 2022, 57 (01) : 34 - 40
  • [24] Predictors for invasive fungal infection in paediatric allogeneic haematopoietic stem cell transplantation recipients
    Hol, J. A.
    Wolfs, T. F. W.
    Bierings, M. B.
    Lindemans, C. A.
    Versluys, A. B. J.
    De Wildt, A.
    Gerhardt, C. E.
    Boelens, J. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S318 - S318
  • [25] Nephrotoxicity of cyclosporine A and amphotericin B-deoxycholate as continuous infusion in allogeneic stem cell transplantation
    Furrer, K
    Schaffner, A
    Vavricka, SR
    Halter, J
    Imhof, A
    Schanz, U
    SWISS MEDICAL WEEKLY, 2002, 132 (23-24) : 316 - 320
  • [26] Optimal dosing regimen of caspofungin in adolescents with allogeneic haematopoietic stem cell transplantation
    Du, Bin
    Zhang, Wei
    Wang, Yang
    Wu, Yue-E
    Zhang, Ya-Hui
    van den Anker, John
    Hao, Guo-Xiang
    Zhao, Wei
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (10) : 2678 - 2687
  • [27] The natural history and control of cytomegalovirus infection following allogeneic stem cell transplantation
    Gamett, G.
    Boeckh, M.
    Einsele, H.
    Emery, V.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S237 - S238
  • [28] Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation
    F Schlemmer
    M Lagrange-Xélot
    C Lacroix
    R de La Tour
    G Socié
    J-M Molina
    Bone Marrow Transplantation, 2008, 42 : 551 - 552
  • [29] Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation
    Shafat, Manar S.
    Mehra, Vedika
    Peggs, Karl S.
    Roddie, Claire
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] Mycobacterium tuberculosis infection following allogeneic peripheral blood stem cell transplantation
    Kerridge, I
    Ethell, M
    Potter, M
    Prentice, HG
    INTERNAL MEDICINE JOURNAL, 2003, 33 (12) : 619 - U6
12345